- $9.09bn
- $8.90bn
- $42.28m
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak
AstraZeneca's eco-friendly version of smoker's lung inhaler gets EU panel backing
Street View: Merck's Verona acquisition fits the script
Europe Research Roundup: British Land, Icade and Sika AG
Press Digest: British Business - July 10
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
Verona hits record high after Merck's $10 billion acquisition
Verona jumps after Merck's $10 billion acquisition
Verona jumps after Merck nearing $10 billion acquisition
Brief: Merck To Acquire Verona Pharma for $10 billion
Merck to acquire Verona Pharma for $10 billion
Verona jumps after report on Merck nearing $10 billion acquisition
Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports (updated)
Brief: Merck Nears $10 Bln Deal For Respiratory Drugmaker Verona- FT
Brief: Verona Pharma Posts Q1 Operating Expenses $86.573 Mln
Brief: Verona Pharma To Report First Quarter 2025 Financial Results And Provide Corporate Update